Literature DB >> 25060255

Thrombotic microangiopathies (TTP, HUS, HELLP).

Shane Kappler1, Sarah Ronan-Bentle2, Autumn Graham3.   

Abstract

Thrombocytopenia, strictly defined as a platelet count less than 150,000, is common in the emergency department. Recognition, diagnostic investigation, and proper disposition of a thrombocytopenic patient are imperative. One group of disorders leading to thrombocytopenia is the thrombotic microangiopathies, hallmarked by platelet destruction. These thrombotic microangiopathies include thrombotic thrombocytopenic purpura (TTP), hemolytic uremic syndrome (HUS) and hemolysis, elevated liver enzyme levels, low platelet count (HELLP), which should be distinguished from similar disease processes such as immune thrombocytopenia (ITP), disseminated intravascular coagulation (DIC) and heparin induced thrombocytopenia (HIT). In this article, clinical presentations, pathophysiology, diagnostic workup, management plans, complications, and dispositions are addressed for this complex group of platelet disorders.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DIC; HELLP; HUS; Hemolytic anemia; ITP; Microangiopathies; TTP; Thrombocytopenia

Mesh:

Substances:

Year:  2014        PMID: 25060255     DOI: 10.1016/j.emc.2014.04.008

Source DB:  PubMed          Journal:  Emerg Med Clin North Am        ISSN: 0733-8627            Impact factor:   2.264


  8 in total

1.  Clinical-Pathological Conference Series from the Medical University of Graz Case No 155: 26-year-old woman in third trimester of pregnancy with epigastric pain and thrombocytopenia.

Authors:  Elisabeth Fabian; Florian Eisner; Ingrid Pabinger; Christian Viertler; Sigrid Regauer; Andreas Lueger; Peter Neumeister; Eva-Christine Weiss; Wolfgang Schöll; Uwe Lang; Florian Prüller; Guenter J Krejs
Journal:  Wien Klin Wochenschr       Date:  2015-08-07       Impact factor: 1.704

Review 2.  Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical use.

Authors:  Americo Cicchetti; Alexandra Berrino; Marina Casini; Paola Codella; Giuseppina Facco; Alessandra Fiore; Giuseppe Marano; Marco Marchetti; Emanuela Midolo; Roberta Minacori; Pietro Refolo; Federica Romano; Matteo Ruggeri; Dario Sacchini; Antonio G Spagnolo; Irene Urbina; Stefania Vaglio; Giuliano Grazzini; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2016-07       Impact factor: 3.443

Review 3.  Pregnancy outcomes of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: a Japanese experience and updated review.

Authors:  Naoyuki Miyasaka; Osamu Miura; Tatsuya Kawaguchi; Nobuyoshi Arima; Eriko Morishita; Kensuke Usuki; Yasuyoshi Morita; Kaichi Nishiwaki; Haruhiko Ninomiya; Akihiko Gotoh; Shinsaku Imashuku; Akio Urabe; Tsutomu Shichishima; Jun-Ichi Nishimura; Yuzuru Kanakura
Journal:  Int J Hematol       Date:  2016-02-08       Impact factor: 2.490

Review 4.  The Differential Diagnosis of Thrombocytopenia in Pregnancy.

Authors:  Frauke Bergmann; Werner Rath
Journal:  Dtsch Arztebl Int       Date:  2015-11-20       Impact factor: 5.594

5.  Complement component 5 promotes lethal thrombosis.

Authors:  Tomohiro Mizuno; Kengo Yoshioka; Masashi Mizuno; Mie Shimizu; Fumihiko Nagano; Tomoyuki Okuda; Naotake Tsuboi; Shoichi Maruyama; Tadashi Nagamatsu; Masaki Imai
Journal:  Sci Rep       Date:  2017-02-16       Impact factor: 4.379

6.  Haemolytic uraemic syndrome - a rare case report of bloody diarrhoea in adults.

Authors:  Shiva Thambiah Radhakrishnan; Aruchuna Ruban; Aarthy Kanmany Uthayakumar; Patrizia Cohen; Jeremy Levy; Julian Teare
Journal:  BMC Gastroenterol       Date:  2019-08-28       Impact factor: 3.067

7.  Effectiveness of high-dose glucocorticoids on hemolysis, elevating liver enzymes, and reducing platelets syndrome.

Authors:  Suya Kang; Liping Zhou; Xiaoyan Wang; Yongmei Li; Yun Wang
Journal:  J Int Med Res       Date:  2018-11-19       Impact factor: 1.671

Review 8.  The Changing Landscape of Acute Kidney Injury in Pregnancy from an Obstetrics Perspective.

Authors:  Angela Vinturache; Joyce Popoola; Ingrid Watt-Coote
Journal:  J Clin Med       Date:  2019-09-06       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.